Tag Archives: pharmaceuticals

Kazakh minister woos Korean investors

EBRD funds cancer treatment in Georgia

DEC. 12 2016 (The Conway Bulletin) — The EBRD issued a €5m ($5.2m) loan to Aversi Pharma, a top-5 healthcare provider in Georgia, for the creation of a new cancer treatment centre in Tbilisi and a clinic in Telavi, in the east of the country. Last year, the EBRD loaned $10.9m to Aversi Pharma to refurbish its hospital in Marneuli, in the south of the country.

ENDS

(News report from Issue No. 309, published on Dec. 16 2016)f

Sanofi enters the fray in Uzbekistan

NOV. 11 2016 (The Conway Bulletin) — French pharmaceuticals company Sanofi entered a partnership with Uzbek state-owned Uzfarmsanoat to produce medicines in the country, official media reported. The Uzbek ministries of health and of international trade said that the deal will focus on the production and circulation of flu vaccines.

ENDS

(News report from Issue No. 305, published on Nov. 18 2016)

Georgia Healthcare Group makes healthcare deal

MAY 5 2016 (The Conway Bulletin) – London-listed Georgia Healthcare Group said it completed the acquisition of GPC for $14m, one of Georgia’s largest retail and wholesale pharmacy chains. Following an agreement signed earlier in March, GHG will now own 100% of GPC. GPC controls 15% of the pharmaceutical market in Georgia.

ENDS

(News report from Issue No. 279, published on May 6 2016)

UK’s Alpha and Uzbekistan’s Fayz Farm sign deal

JAN. 14 2016 (The Conway Bulletin) — UK-based Alpha Pharm Trading and Uzbekistan’s Fayz Farm signed a deal to create a joint venture to produce medicines in the Navoi free industrial economic zone. The joint venture, called Novo Farm Komplekt, will invest $3.7m in a factory and distribution centre for pharmaceutical products.

ENDS

(News report from Issue No. 263, published on Jan. 15 2016)

New pharma factory to open in Georgia

DEC. 25 2016 (The Conway Bulletin) — The Georgian government and Austrian company Humanity Holding will team up to build a $130m pharmaceutical factory in Tbilisi. Humanity established a daughter company, Humanity Georgia, to run the project. The factory will produce 800 pharmaceutical products. Humanity Georgia will also import pharmaceutical products from abroad. Georgia’s state-owned Partnership Fund will co-fund the project.

ENDS

(News report from Issue No. 262, published on Jan. 8 2016)

Stock market: Tethys, Nostrum, GHG

NOV. 27 2015 (The Conway Bulletin) — Oil producers suffered in the London stock market this week, due to mixed industrial announcements.

Tethys Petroleum shares lost 13% in one week closing at 4.25p on Friday. Nostrum Oil & Gas was on track to a similar fall after it lost 9% on Monday, recovering later in the week after it showed its investment plans for a new gas treatment facility. On Friday, Nostrum closed at 376p, down 3.5%. Roxi Petroleum shares closed at 7.75p on Friday, down 5% from last week.

Central Asia Metals lost 2.2% this week to close at 161.5p on Friday, while the other major miner in Kazakhstan, KAZ Minerals, gained 7.8% to 99.8p.

Newly-listed Georgia Healthcare Group lost around 2% this week to close at 177p on Friday.

ENDS

(News report from Issue No. 258, published on Nov. 27 2015)

Stock market: GHG, Nostrum, KAZ Minerals

NOV. 10 2015 (The Conway Bulletin) — As the Bulletin reports on its front page, Georgia Healthcare Group (GHG) listed on the London Stock Exchange with an initial share price of 170p on Nov. 9. The company listed 29% of its shares, valuing the company around £218m ($331m). By Friday its shares had dropped to 181p.

Oil and commodities companies lost ground on the London stock market after Brent and copper prices fell by 6% and 4.5% this week.

Linked to this fall in the price of Brent crude futures, Kazakhstan-focused Nostrum Oil & Gas shares were down 16% closing at 367.5p. Nostrum recorded an 8% fall on Thursday, placing its shares among the worst performers on the FTSE 250.

Cooper producer KAZ Minerals, formerly known as Kazakhmys, faired worse. Its shares fell by 20% over the week, closing at 80p.

Tethys Petroleum shares jumped by 53% on Monday following Olisol’s letter of intent to acquire its stakes, but finished the week down to 4.25p.

ENDS

(News report from Issue No. 256, published on Nov. 13 2015)

Tajik-Japanese joint venture to build factory

OCT. 29 2015 (The Conway Bulletin) — Avvalin, a joint-venture between Japan’s Cokey Systems and the Tajik government, wants to build a factory to produce liquorice root-based medicines. Tajikistan produces liquorice in the south-west of the country. The Tajik government owns 51% of Avvalin. Cokey owns 49%.

ENDS

(News report from Issue No. 254, published on Oct. 30 2015)

Medicine exports increase in Georgia

APRIL 17 2015 (The Conway Bulletin) – Georgia’s pharmaceuticals industry is growing fast, data from the statistics agency Geostat showed.

In 2014, Georgian pharmaceuticals companies exports to other CIS countries increased by nearly 50%, Geostat said.

A pharmaceuticals director at a local company said it was because domestic rules changed last year and meant that people needed prescriptions to buy more drugs. This in turn pushed pharmaceutical makers to find new markets for their drugs.

“The increase in exports was caused by the increased number of medication for export and if earlier the company sold 20 varieties of medicines abroad, today the list includes more than 50,” Boris Jijolava, export manager at Georgian pharmaceuticals maker GMP told the Caucasian Business Week website.

Geostat said the value of drugs exported by Georgian companies to the former Soviet Union increased to around $92m in 2014 from $52m in 2013.

ENDS

(News report from Issue No. 228, published on April 22 2015)